Literature DB >> 20686047

Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling.

Jelke J Fros1, Wen Jun Liu, Natalie A Prow, Corinne Geertsema, Maarten Ligtenberg, Dana L Vanlandingham, Esther Schnettler, Just M Vlak, Andreas Suhrbier, Alexander A Khromykh, Gorben P Pijlman.   

Abstract

Chikungunya virus (CHIKV) is an emerging human pathogen transmitted by mosquitoes. Like that of other alphaviruses, CHIKV replication causes general host shutoff, leading to severe cytopathicity in mammalian cells, and inhibits the ability of infected cells to respond to interferon (IFN). Recent research, however, suggests that alphaviruses may have additional mechanisms to circumvent the host's antiviral IFN response. Here we show that CHIKV replication is resistant to inhibition by interferon once RNA replication has been established and that CHIKV actively suppresses the antiviral IFN response by preventing IFN-induced gene expression. Both CHIKV infection and CHIKV replicon RNA replication efficiently blocked STAT1 phosphorylation and/or nuclear translocation in mammalian cells induced by either type I or type II IFN. Expression of individual CHIKV nonstructural proteins (nsPs) showed that nsP2 was a potent inhibitor of IFN-induced JAK-STAT signaling. In addition, mutations in CHIKV-nsP2 (P718S) and Sindbis virus (SINV)-nsP2 (P726S) that render alphavirus replicons noncytopathic significantly reduced JAK-STAT inhibition. This host shutoff-independent inhibition of IFN signaling by CHIKV is likely to have an important role in viral pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20686047      PMCID: PMC2950581          DOI: 10.1128/JVI.00949-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  40 in total

1.  Complementation analysis of the flavivirus Kunjin NS3 and NS5 proteins defines the minimal regions essential for formation of a replication complex and shows a requirement of NS3 in cis for virus assembly.

Authors:  Wen Jun Liu; Petra L Sedlak; Natasha Kondratieva; Alexander A Khromykh
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Roles of nonstructural protein nsP2 and Alpha/Beta interferons in determining the outcome of Sindbis virus infection.

Authors:  Elena I Frolova; Rafik Z Fayzulin; Susan H Cook; Diane E Griffin; Charles M Rice; Ilya Frolov
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Biogenesis of the Semliki Forest virus RNA replication complex.

Authors:  P Kujala; A Ikäheimonen; N Ehsani; H Vihinen; P Auvinen; L Kääriäinen
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

4.  Chikungunya infection--an emerging disease in Malaysia.

Authors:  S K Lam; K B Chua; P S Hooi; M A Rahimah; S Kumari; M Tharmaratnam; S K Chuah; D W Smith; I A Sampson
Journal:  Southeast Asian J Trop Med Public Health       Date:  2001-09       Impact factor: 0.267

5.  Chikungunya virus arthritis in adult wild-type mice.

Authors:  Joy Gardner; Itaru Anraku; Thuy T Le; Thibaut Larcher; Lee Major; Pierre Roques; Wayne A Schroder; Stephen Higgs; Andreas Suhrbier
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

6.  Type I IFN controls chikungunya virus via its action on nonhematopoietic cells.

Authors:  Clémentine Schilte; Thérèse Couderc; Fabrice Chretien; Marion Sourisseau; Nicolas Gangneux; Florence Guivel-Benhassine; Anton Kraxner; Jürg Tschopp; Stephen Higgs; Alain Michault; Fernando Arenzana-Seisdedos; Marco Colonna; Lucie Peduto; Olivier Schwartz; Marc Lecuit; Matthew L Albert
Journal:  J Exp Med       Date:  2010-02-01       Impact factor: 14.307

7.  Modulation of type I IFN induction by a virulence determinant within the alphavirus nsP1 protein.

Authors:  Catherine C Cruz; Mehul S Suthar; Stephanie A Montgomery; Reed Shabman; Jason Simmons; Robert E Johnston; Thomas E Morrison; Mark T Heise
Journal:  Virology       Date:  2010-01-25       Impact factor: 3.616

8.  Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation.

Authors:  Michela Mazzon; Meleri Jones; Andrew Davidson; Benjamin Chain; Michael Jacobs
Journal:  J Infect Dis       Date:  2009-10-15       Impact factor: 5.226

9.  Venezuelan equine encephalitis virus disrupts STAT1 signaling by distinct mechanisms independent of host shutoff.

Authors:  Jason D Simmons; Laura J White; Thomas E Morrison; Stephanie A Montgomery; Alan C Whitmore; Robert E Johnston; Mark T Heise
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

10.  Alphavirus minus-strand synthesis and persistence in mouse embryo fibroblasts derived from mice lacking RNase L and protein kinase R.

Authors:  Dorothea L Sawicki; Robert H Silverman; Bryan R Williams; Stanley G Sawicki
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more
  115 in total

Review 1.  Chikungunya virus: evolution and genetic determinants of emergence.

Authors:  Konstantin A Tsetsarkin; Rubing Chen; Michael B Sherman; Scott C Weaver
Journal:  Curr Opin Virol       Date:  2011-10       Impact factor: 7.090

2.  Interferon-alpha/beta deficiency greatly exacerbates arthritogenic disease in mice infected with wild-type chikungunya virus but not with the cell culture-adapted live-attenuated 181/25 vaccine candidate.

Authors:  Christina L Gardner; Crystal W Burke; Stephen T Higgs; William B Klimstra; Kate D Ryman
Journal:  Virology       Date:  2012-02-01       Impact factor: 3.616

3.  ADP-ribosylhydrolase activity of Chikungunya virus macrodomain is critical for virus replication and virulence.

Authors:  Robert Lyle McPherson; Rachy Abraham; Easwaran Sreekumar; Shao-En Ong; Shang-Jung Cheng; Victoria K Baxter; Hans A V Kistemaker; Dmitri V Filippov; Diane E Griffin; Anthony K L Leung
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-31       Impact factor: 11.205

4.  The C-terminal domain of chikungunya virus nsP2 independently governs viral RNA replication, cytopathicity, and inhibition of interferon signaling.

Authors:  Jelke J Fros; Erika van der Maten; Just M Vlak; Gorben P Pijlman
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

Review 5.  Insect antiviral innate immunity: pathways, effectors, and connections.

Authors:  Megan B Kingsolver; Zhijing Huang; Richard W Hardy
Journal:  J Mol Biol       Date:  2013-10-09       Impact factor: 5.469

6.  A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence.

Authors:  Thomas E Morrison; Lauren Oko; Stephanie A Montgomery; Alan C Whitmore; Alina R Lotstein; Bronwyn M Gunn; Susan A Elmore; Mark T Heise
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

7.  Lack of nsP2-specific nuclear functions attenuates chikungunya virus replication both in vitro and in vivo.

Authors:  Chetan D Meshram; Tetyana Lukash; Aaron T Phillips; Ivan Akhrymuk; Elena I Frolova; Ilya Frolov
Journal:  Virology       Date:  2019-05-28       Impact factor: 3.616

8.  BST-2/tetherin-mediated restriction of chikungunya (CHIKV) VLP budding is counteracted by CHIKV non-structural protein 1 (nsP1).

Authors:  Philip H Jones; Martina Maric; Marisa N Madison; Wendy Maury; Richard J Roller; Chioma M Okeoma
Journal:  Virology       Date:  2013-02-12       Impact factor: 3.616

9.  Noncoding flavivirus RNA displays RNA interference suppressor activity in insect and Mammalian cells.

Authors:  Esther Schnettler; Mark G Sterken; Jason Y Leung; Stefan W Metz; Corinne Geertsema; Rob W Goldbach; Just M Vlak; Alain Kohl; Alexander A Khromykh; Gorben P Pijlman
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

10.  Novel Mutations in nsP2 Abolish Chikungunya Virus-Induced Transcriptional Shutoff and Make the Virus Less Cytopathic without Affecting Its Replication Rates.

Authors:  Ivan Akhrymuk; Tetyana Lukash; Ilya Frolov; Elena I Frolova
Journal:  J Virol       Date:  2019-02-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.